This is my archive
News & Blog
19 April 2022
Pathfinder invests in Selmo.io, Facebook sellers’ assistant Tar Heel Capital Pathfinder has invested in Selmo.io, a platform that makes it easier for stores to sell on Facebook and via livestreams. The Selmo app offers a number of functionalities that turn Messenger into an effective sales channel, speed up the process of collecting orders and help increase the number of closed transactions. 24 March 2022
CMK backed by new investor enters next stage of development Centrum Medycyny Konopnej (The Centre for Cannabis-Based Medicine), a facility providing services based on medical marijuana therapies, has been backed by a new investor - the WP2 Investments fund. Grzegorz Ciężadło, a manager experienced in the development of innovative businesses on the medical market, has joined the CMK's management. In the coming weeks the clinic is launching its first facility in Warsaw. 5 January 2022
Pathfinder’s venture building team expands Marek Friedman, a C-level executive with over 20 years experience in managing companies operating in media and e-commerce sectors, among others, has joined the fund’s team as an Interim CEO of its portfolio companies. 24 November 2021
Jan Brandes joins Tar Heel Capital Pathfinder as advisor Jan Brandes, a corporate finance expert, joins Pathfinder’s team to leverage his over 16’ years experience in advising leading European tech companies and investors for the benefit of the startups from our portfolio. 9 November 2021
RemoteMyApp moves to the next level: Polish tech startup acquired by international corporation RemoteMyApp, a Szczecin-based startup providing technology and services for streaming games from the cloud to international corporations, will itself become the property of a global player: the company has been acquired by Intel Corporation. 16 September 2021
A strong debut of Woodpecker on NewConnect Another company from the portfolio of Tar Heel Capital Pathfinder has begun its journey in the capital markets. Woodpecker.co made its debut on the alternative market of the Warsaw Stock Exchange. The company is already planning the next step: transitioning to the main stock exchange. 24 August 2021
NaturalAntibody: Oxford scientist joins forces with Tar Heel Capital Pathfinder to revolutionise the process of drug manufacturing Tar Heel Capital Pathfinder is investing in the revolution in the pharma industry. The fund joined forces with the world-class expert in the field of bioinformatic antibody analysis, Dr. Konrad Krawczyk. Together, they created NaturalAntibody, a company offering bioinformatic solutions that allow to significantly reduce the costs and accelerate the process of bringing antibody-based drugs to the market. The company’s products are already used by AstraZeneca, among others. 16 August 2021
Unikrn to be acquired by the betting and gaming giant, Entain Entain, one of the world’s largest sports betting and gaming businesses, has announced its acquisition of Unikrn, a leading esports betting and entertainment media company and a portfolio company of Tar Heel Capital Pathfinder.
Pathfinder invests in Selmo.io, Facebook sellers’ assistant Tar Heel Capital Pathfinder has invested in Selmo.io, a platform that makes it easier for stores to sell on Facebook and via livestreams. The Selmo app offers a number of functionalities that turn Messenger into an effective sales channel, speed up the process of collecting orders and help increase the number of closed transactions. 24 March 2022
CMK backed by new investor enters next stage of development Centrum Medycyny Konopnej (The Centre for Cannabis-Based Medicine), a facility providing services based on medical marijuana therapies, has been backed by a new investor - the WP2 Investments fund. Grzegorz Ciężadło, a manager experienced in the development of innovative businesses on the medical market, has joined the CMK's management. In the coming weeks the clinic is launching its first facility in Warsaw. 5 January 2022
Pathfinder’s venture building team expands Marek Friedman, a C-level executive with over 20 years experience in managing companies operating in media and e-commerce sectors, among others, has joined the fund’s team as an Interim CEO of its portfolio companies. 24 November 2021
Jan Brandes joins Tar Heel Capital Pathfinder as advisor Jan Brandes, a corporate finance expert, joins Pathfinder’s team to leverage his over 16’ years experience in advising leading European tech companies and investors for the benefit of the startups from our portfolio. 9 November 2021
RemoteMyApp moves to the next level: Polish tech startup acquired by international corporation RemoteMyApp, a Szczecin-based startup providing technology and services for streaming games from the cloud to international corporations, will itself become the property of a global player: the company has been acquired by Intel Corporation. 16 September 2021
A strong debut of Woodpecker on NewConnect Another company from the portfolio of Tar Heel Capital Pathfinder has begun its journey in the capital markets. Woodpecker.co made its debut on the alternative market of the Warsaw Stock Exchange. The company is already planning the next step: transitioning to the main stock exchange. 24 August 2021
NaturalAntibody: Oxford scientist joins forces with Tar Heel Capital Pathfinder to revolutionise the process of drug manufacturing Tar Heel Capital Pathfinder is investing in the revolution in the pharma industry. The fund joined forces with the world-class expert in the field of bioinformatic antibody analysis, Dr. Konrad Krawczyk. Together, they created NaturalAntibody, a company offering bioinformatic solutions that allow to significantly reduce the costs and accelerate the process of bringing antibody-based drugs to the market. The company’s products are already used by AstraZeneca, among others. 16 August 2021
Unikrn to be acquired by the betting and gaming giant, Entain Entain, one of the world’s largest sports betting and gaming businesses, has announced its acquisition of Unikrn, a leading esports betting and entertainment media company and a portfolio company of Tar Heel Capital Pathfinder.